Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (621-630 of 924) with videos related to

Pageof 93
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expressionA Psyrri, P Kountourakis, A Scorilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancerA Magklara, A Scorilas, D Katsaros, et al.
Molecular Oncology|April 23, 2009
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancerJane Bayani, Miltiadis Paliouras, Chris Planque, et al.
Clinical Chemistry and Laboratory Medicine|February 4, 2017
Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validationLampros Dimitrakopoulos, Ioannis Prassas, Els M J J Berns, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2003
Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissuesC D Petraki, A K Gregorakis, P A Papanastasiou, et al.
BJU International|August 18, 2005
Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detectionCarsten Stephan, Klaus Jung, Antoninus Soosaipillai, et al.
Journal of the American Pharmacists Association : Japha|August 4, 2024
Establishing mental health friendly pharmacies to assist in the early identification and support of older adults at risk of depression: The EMPATHISE pilot studyDuha N Gide, Sarira El-Den, Lisa Kouladjian O'Donnell, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 25, 2006
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot studyKaterina Oikonomopoulou, Andreas Scorilas, Iacovos P Michael, et al.
Clinical Chemistry|August 19, 2006
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosolsShannon J C Shan, Andreas Scorilas, Dionyssios Katsaros, et al.
Experimental Dermatology|May 24, 2007
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patientsNahoko Komatsu, Kiyofumi Saijoh, Cynthia Kuk, et al.
Pageof 93

Showing results (621-630 of 924) with videos related to

Sort By:
Pageof 93
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expressionA Psyrri, P Kountourakis, A Scorilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancerA Magklara, A Scorilas, D Katsaros, et al.
Molecular Oncology|April 23, 2009
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancerJane Bayani, Miltiadis Paliouras, Chris Planque, et al.
Clinical Chemistry and Laboratory Medicine|February 4, 2017
Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validationLampros Dimitrakopoulos, Ioannis Prassas, Els M J J Berns, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2003
Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissuesC D Petraki, A K Gregorakis, P A Papanastasiou, et al.
BJU International|August 18, 2005
Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detectionCarsten Stephan, Klaus Jung, Antoninus Soosaipillai, et al.
Journal of the American Pharmacists Association : Japha|August 4, 2024
Establishing mental health friendly pharmacies to assist in the early identification and support of older adults at risk of depression: The EMPATHISE pilot studyDuha N Gide, Sarira El-Den, Lisa Kouladjian O'Donnell, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 25, 2006
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot studyKaterina Oikonomopoulou, Andreas Scorilas, Iacovos P Michael, et al.
Clinical Chemistry|August 19, 2006
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosolsShannon J C Shan, Andreas Scorilas, Dionyssios Katsaros, et al.
Experimental Dermatology|May 24, 2007
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patientsNahoko Komatsu, Kiyofumi Saijoh, Cynthia Kuk, et al.
Pageof 93